File Download
Supplementary

postgraduate thesis: Coronaviruses exploit a host cysteine-aspartic protease for replication

TitleCoronaviruses exploit a host cysteine-aspartic protease for replication
Authors
Advisors
Advisor(s):Yuen, KYChu, H
Issue Date2022
PublisherThe University of Hong Kong (Pokfulam, Hong Kong)
Citation
Hou, Y. [侯宇昕]. (2022). Coronaviruses exploit a host cysteine-aspartic protease for replication. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR.
AbstractHighly pathogenic coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Middle East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV-1 vary in their transmissibility and pathogenicity. The mechanism underlying these differences remains largely unexplained. However, substantial apoptosis induced by infection of all three viruses have been documented in infected cells and patient tissues, suggesting a previously unrecognized link between apoptosis cascade and the pathogenesis of coronaviruses. In this study, I show that caspase-6, a cysteine-aspartic protease which is the central component involved in apoptosis cascade, serves as an important host factor for efficient coronavirus replication. I demonstrate that caspase-6 cleaves coronavirus nucleocapsid (N) proteins, generating N fragments that serve as interferon (IFN) antagonists, thus facilitating virus replication. Inhibition of caspase-6 reduces the replication of all evaluated human pathogenic coronaviruses including human coronavirus 229E (HCoV-229E), human coronavirus OC43 (HCoV-OC43), SARS-CoV-1, MERS-CoV and SARS-CoV-2 in vitro. In human ex vivo lung tissues and human intestinal organoids, inhibition of caspase-6 limits the replication of MERS-CoV. Importantly, inhibition of caspase-6 markedly attenuates the replication of SARS-CoV-2 in infected lungs and substantially ameliorates the lung pathology, leading to significant improvement of body weight loss in SARS-CoV-2-infected golden Syrian hamsters. Similarly, inhibition of caspase-6 dramatically reduces the replication of MERS-CoV in infected lungs and improves the survival of mouse-adapted MERS-CoV (MERS-CoVMA)-infected human DPP4 knock-in (hDPP4 KI) mice. These findings are further validated with caspase-6 knockout in the hDPP4 KI mice, which shows significantly attenuated MERS-CoV replication in infected lungs in comparison to the caspase-6 intact mice. Overall, my study reveals how coronaviruses exploit a component of the host apoptosis cascade to facilitate virus replication.
DegreeDoctor of Philosophy
SubjectCoronaviruses
Proteolytic enzymes
Dept/ProgramMicrobiology
Persistent Identifierhttp://hdl.handle.net/10722/323726

 

DC FieldValueLanguage
dc.contributor.advisorYuen, KY-
dc.contributor.advisorChu, H-
dc.contributor.authorHou, Yuxin-
dc.contributor.author侯宇昕-
dc.date.accessioned2023-01-09T01:48:48Z-
dc.date.available2023-01-09T01:48:48Z-
dc.date.issued2022-
dc.identifier.citationHou, Y. [侯宇昕]. (2022). Coronaviruses exploit a host cysteine-aspartic protease for replication. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR.-
dc.identifier.urihttp://hdl.handle.net/10722/323726-
dc.description.abstractHighly pathogenic coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Middle East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV-1 vary in their transmissibility and pathogenicity. The mechanism underlying these differences remains largely unexplained. However, substantial apoptosis induced by infection of all three viruses have been documented in infected cells and patient tissues, suggesting a previously unrecognized link between apoptosis cascade and the pathogenesis of coronaviruses. In this study, I show that caspase-6, a cysteine-aspartic protease which is the central component involved in apoptosis cascade, serves as an important host factor for efficient coronavirus replication. I demonstrate that caspase-6 cleaves coronavirus nucleocapsid (N) proteins, generating N fragments that serve as interferon (IFN) antagonists, thus facilitating virus replication. Inhibition of caspase-6 reduces the replication of all evaluated human pathogenic coronaviruses including human coronavirus 229E (HCoV-229E), human coronavirus OC43 (HCoV-OC43), SARS-CoV-1, MERS-CoV and SARS-CoV-2 in vitro. In human ex vivo lung tissues and human intestinal organoids, inhibition of caspase-6 limits the replication of MERS-CoV. Importantly, inhibition of caspase-6 markedly attenuates the replication of SARS-CoV-2 in infected lungs and substantially ameliorates the lung pathology, leading to significant improvement of body weight loss in SARS-CoV-2-infected golden Syrian hamsters. Similarly, inhibition of caspase-6 dramatically reduces the replication of MERS-CoV in infected lungs and improves the survival of mouse-adapted MERS-CoV (MERS-CoVMA)-infected human DPP4 knock-in (hDPP4 KI) mice. These findings are further validated with caspase-6 knockout in the hDPP4 KI mice, which shows significantly attenuated MERS-CoV replication in infected lungs in comparison to the caspase-6 intact mice. Overall, my study reveals how coronaviruses exploit a component of the host apoptosis cascade to facilitate virus replication. -
dc.languageeng-
dc.publisherThe University of Hong Kong (Pokfulam, Hong Kong)-
dc.relation.ispartofHKU Theses Online (HKUTO)-
dc.rightsThe author retains all proprietary rights, (such as patent rights) and the right to use in future works.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subject.lcshCoronaviruses-
dc.subject.lcshProteolytic enzymes-
dc.titleCoronaviruses exploit a host cysteine-aspartic protease for replication-
dc.typePG_Thesis-
dc.description.thesisnameDoctor of Philosophy-
dc.description.thesislevelDoctoral-
dc.description.thesisdisciplineMicrobiology-
dc.description.naturepublished_or_final_version-
dc.date.hkucongregation2023-
dc.identifier.mmsid991044625592503414-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats